GEN Biomarket Trends Report LDTs Based on Mass Spec

8/13/2019 GEN Biomarket Trends Report LDTs Based on Mass Spec

1/17

!"#$%&'()*+ -.(/%) 0 1%23 45.67*8*9"#$%&'(% )* +,-. /-0123 "4565 789:!"#%5:5%;*


2/17

!"#$%&'()*+ -.(/%) 0 1%23 45.67*8*9"#$%&'(% )* +,-. /-0123 "4565 789:!"#%5:5%;* )3% =.** *&%2)('=%)(7 *&.2% .* 8)* )(.5*6.@5: >('=

(%*%.(23 )' 268582

B% 3.A% C%%5 >'66';85: )3% =.** *&%2)('=%)(7 =.(/%)&6.2% .5DC.*%D '5 '?( .5.67*%* 3.A% 8D%5@E%D .(%.* '> '&&'()?58)7F'5% '>

)3%*% .(%.* '> '&&'()?58)7 8* )3% ?@68G.@'5 '> =.** *&%2)('=%)(7 >'(268582.6 D8.:5'*@2*

;42< 2< -, (=(#>2,> ?(.% -,% @4(#( -#( '#(,@.* - .-#>( ,&=)(# $A .-)$#-@$#*%(1(.$B(% @(


3/17

!"#$%&'()*+ -.(/%) 0 1%23 45.67*8*9"#$%&'(% )* +,-. /-0123 "4565 789:!"#%5:5%;* 4C?*%

1%*@5:

RM';5*)(%.=

4**.7T

I(%5.).6 1%*@5:

-%).C'68)%

1%*@5: R449 V4T

H)%('8D* R"5D'2(85%

M8*'(D%(*F. =.W'(

D(8A%(T9 P8).=85*

-82('C8'6':7


4/17

!"#$%&'()*+ -.(/%) 0 1%23 45.67*8*9"#$%&'(% )* +,-. /-0123 "4565 789:!"#%5:5%;*'(=.@'5

'5 45.67)%R*T K5)%((':.)%D

I(J&(,$= K(,@(# A$# L$.('&.-# L(%2'2,( K* LOD6HP;QN LI

;(,(,$.$,( %(@('M$, A$# KOY CK$,>(,2@-. O%#(,-. Y*B(#B.-.*'2,(P'$,_&>-@( -,% @-,(P'$,_&>-@( A$#=< $A

'4$.2' -'2%3 '4(,$%($`*'4$.2' -'2%3 %($`*'4$.2' -'2%3 -,% ,$


5/17

!"#$%&'()*+ -.(/%) 0 1%23 45.67*8*9"#$%&'(% )* +,-. /-0123 "4565 789:!"#%5:5%;*'(=.@'5 '5

45.67)%R*T K5)%((':.)%D

"(#S2, +.=(# C"cHE W(,(M'4K9: (,-


6/17

!"#$%&'()*+ -.(/%) 0 1%23 45.67*8*9"#$%&'(% )* +,-. /-0123 "4565 789:!"#%5:5%;*'(=.@'5 '5

45.67)%R*T K5)%((':.)%D

L-*$ K.2,2' CL-*$ L(%2'-.

D-)$#-@$#2(2,2,(3 B4$


7/17

!"#$%&'()*+ -.(/%) 0 1%23 45.67*8*9"#$%&'(% )* +,-. /-0123 "4565 789:!"#%5:5%;*'(=.@'5 '5 45.67)%R*T K5)%((':.)%D

7L O(,--,2' O'2% L(@-)$.2


8/17

!"#$%&'()*+ -.(/%) 0 1%23 45.67*8*9"#$%&'(% )* +,-. /-0123 "4565 789:!"#%5:5%;*'(=.@'5 '5

45.67)%R*T K5)%((':.)%D6(,1(# W(,(M' D-)$#-@$#2(< "-(%2-@#2' Y(B-@$#(,-. ;*#$ $A =2@$'4$,%#2- P b-#@4 I*,%#$=( -,% 62.-@(% K-#%2$=*$B-@4* WK]LI RPL(@4*.>.&@-'$,2' O'2%

O=,2$M' N.&2% -,% ^&-,M@-M1( %2->,$-,2' -'2%(=2- %2$]A#(( >.*'-, B#$?.(< I'#((, G2@4 /(i(` @$ K$,?#=-M$, DKPLI]LI

K$'-2,( K$,?#=-M$, DKPLI]LI

N#(( a ;$@-. K-#,2M,( DKPLI]LI

D*2' O'2% 62(@4*.-=2%( CDI6E DKPLI]LI

L(@4-%$,( K$,?#=-M$, DKPLI]LI

L2


9/17

!"#$%&'()*+ -.(/%) 0 1%23 45.67*8*9"#$%&'(% )* +,-. /-0123 "4565 789:!"#%5:5%;*'(=.@'5 '5 45.67)%R*T K5)%((':.)%D[-.( V(G Y-1(, Y$(,$


10/17

!"#$%&'()*+ -.(/%) 0 1%23 45.67*8*9"#$%&'(% )* +,-. /-0123 "4565 789:!"#%5:5%;*'(=.@'5 '5 45.67)%R*T K5)%((':.)%DO#&B D-)$#-@$#2(E

^&-,M@-M1( Y2>4 "(#A$#=-,'( D2J&2%

K4#$=-@$>#-B4*P;-,%(= L--. L$,2@$#2,> P C62i&'-,O,@$A&,>-. 6#&>E

^&-,M@-M1( Y2>4 "(#A$#=-,'( D2J&2%K4#$=-@$>#-B4*P;-,%(= L- L$,2@$#2,> P CK2B#-=2.3

K(.(`- O,M%(B#(#-B4*PL-


11/17

!"#$%&'()*+ -.(/%) 0 1%23 45.67*8*9"#$%&'(% )* +,-. /-0123 "4565 789:!"#%5:5%;*'(=.@'5 '5 45.67)%R*T

K5)%((':.)%D

L2'#$)2$.$>*3 b-#@< -,% ;4(

D$,%$, VYI ;#& A$# %2


12/17

!"#$%&'()*+ -.(/%) 0 1%23 45.67*8*9"#$%&'(% )* +,-. /-0123 "4565 789:!"#%5:5%;*'(=.@'5 '5 45.67)%R*T

K5)%((':.)%D

W4(,@ \,21(#2&= b-'@(#2-. IB('2(< H%(,M?'-M$, LOD6HP;QN LI D(&'$,$ L$,2@$#2,> A$# @4( @#(-@=(,@

$A ;&)(#'&.$ L$,2@$#2,> P +@4-=)&@$. WK]LI +@4-=)&@$.

;4(#-B(&M' 6#&> L$,2@$#2,> P "*#-02,-=2%( WK]LI "*#-02,-=2%(

V($(,%$'#2,( ;&=$# 62->,$ L$,2@$#2,> P /-B-=&,( a/-B-=*'2, C,$, L$,2@$#2,> ;-,%(= LI /2


13/17

!"#$%&'()*+ -.(/%) 0 1%23 45.67*8*9"#$%&'(% )* +,-. /-0123 "4565 789:!"#%5:5%;*'(=.@'5 '5 45.67)%R*T

K5)%((':.)%D

K-,@$,-. H,*

I42=-%0& O`2=-K$,?%(,'( LOD6H ;QN

LI I@&%* 9X7 '.2,2'-. 2,$ A$# 2,)$#, (##$#< & ".- A$# 2,)$#, (##$#< & \#2,( b2.(

O'2% O,-.*


14/17

!"#$%&'()*+ -.(/%) 0 1%23 45.67*8*9"#$%&'(% )* +,-. /-0123 "4565 789:!"#%5:5%;*'(=.@'5 '5 45.67)%R*T

K5)%((':.)%D

c2,>< K$..(>( Y$ P $A K(..K(B@ -,% L*A$#M' & L$,2@$#2,> P K(#M'-, -B4*P@-,%(=

=-#-B4*P@-,%(=

=-#-B4*P@-,%(=

=-,-,'2( =(@-)$.2@(


15/17

!"#$%&'()*+ -.(/%) 0 1%23 45.67*8*9"#$%&'(% )* +,-. /-0123 "4565 789:!"#%5:5%;*'(=.@'5 '5 45.67)%R*T

K5)%((':.)%D

bK b2$=(%2'-.

D-)$#-@$#2(< P K-,-%- L2'#$)2$.$>*]"-@4$>(, H%(,M?'-M$, LOD6H ;QN

W#-= V(>-M1( )-'@(#2-3 >#-= B$ -,% -&@$=-M' '$,?#=-M$, $A

B$-,

Y$(, 6(@('M$, P H, -


16/17

!"#$%&'()*+ -.(/%) 0 1%23 45.67*8*9"#$%&'(% )* +,-. /-0123 "4565 789:!"#%5:5%;*'(=.@'5 '5 45.67)%R*T

K5)%((':.)%D

\,21(#


17/17

!"#$%&'()*+ -.(/%) 0 1%23 45.67*8*9"#$%&'(% )* +,-. /-0123 "4565 789:!"#%5:5%;*'2?*85: '5

)3% A.(8'?* LM1* )3.) 3.A% C%%5 D%A%6'&%D C.*%D ?&'5

=.** *&%2)('=%)(7 .* . (%.D'?)

13%(% .(% =.57 LM1* C.*%D '5 =.** *&%2)('=%)(72?((%5)67 .DD(%**85: . 5?=C%( '> .5.67)%*

13% 23.66%5:% 3.* C%%5 )3% )(.5*6.@'5 '> )3%*% LM1*85)' VM4Q.&&('A%D !"#$ &'(D8.:5'*@2 )%*)* RKPM*T

;42< G2.. )( -%%#(

GEN Biomarket Trends Report LDTs Based on Mass Spec

Documents